Johns Hopkins Diabetes GuideMedicationsObesity

Naltrexone/Buproprion

Clare Lee, M.D., Brian Pinto, Pharm.D.
Naltrexone/Buproprion is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Naltrexone/bupropion was approved as an adjunct to diet and exercise in adults with BMI ≥30 kg/m2 or ≥27 kg/m2 with one or more weight-related comorbidities to achieve weight loss.

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: October 19, 2015